§ 01 - PRESENT TENSEThe office where the MRI lives down the hall
Walk into a modern urology clinic on a Tuesday morning. The waiting room is full of men in their sixties. A nurse calls a name, and the patient does not get loaded into an ambulance, or sent across town to a hospital basement, or scheduled three weeks out for a tube-shaped scanner the size of a small car. He walks down the hall. Into a normal exam room. And lies down next to a magnet that looks more like a tanning bed than a piece of imaging equipment.
This is the room Promaxo is trying to fill. Not next year - now. The Promaxo MRI System is FDA 510(k)-cleared for MRI-guided prostate biopsy, and it is doing something the imaging industry spent three decades calling impractical: putting a real magnetic resonance imager inside a private clinic, with no faraday cage, no liquid helium refill schedule, and no architectural retrofit.
It is a small bet about a big idea. The big idea: cancer care moves where the patient already is. The small bet: a magnet only needs one side.
§ 02 - THE PROBLEMProstate care has a logistics problem
About one in eight American men will be diagnosed with prostate cancer. The standard pathway runs through a series of expensive appointments, in expensive rooms, on expensive machines, scheduled around the lives of hospital radiologists. A patient with an elevated PSA result might wait weeks for an MRI, then weeks more for a biopsy, then weeks again for a treatment plan. The cancer, of course, does not wait.
The bottleneck is not skill - urologists are perfectly capable of performing targeted biopsies. The bottleneck is the imaging stack. Conventional MRI is a marvel of physics and a nightmare of facilities planning. The magnet is heavy. The cryogenics are fussy. The shielding requirements are baroque. So MRI lives in hospitals, and patients orbit the hospitals.
Promaxo's founders looked at this and asked a slightly impertinent question: what if the patient orbit was the wrong loop?
§ 03 - THE BETOne-sided magnets, two-handed founders
In 2016, Dr. Amit Vohra - a physicist and entrepreneur with a doctorate in materials science and an MBA on top of it - co-founded Promaxo in Oakland with the proposition that an MRI does not have to be a tube. It can be a slab. A single-sided magnet generates its field on one face, not all around the patient, which means the field can be tuned to image a specific anatomy - say, a prostate - without enveloping the rest of the body. The fringe field shrinks. The shielding burden disappears. The room requirements collapse into something you could plumb into a strip-mall clinic.
Most physicists, on hearing this pitch, would politely point out the trade-offs. Single-sided magnets have weaker, less uniform fields than traditional MRI. The signal-to-noise ratio is harder. The image reconstruction is harder. The acquisition sequences are harder. Almost everything, in fact, is harder.
Promaxo accepted the harder. The bet was that artificial intelligence - applied to reconstruction, denoising, and lesion targeting - could close the quality gap that physics opened. Combined with robotic needle guidance and a clinician workflow built around urologists rather than radiologists, the single-sided magnet stopped being a compromise and started being a category.
§ 04 - THE PRODUCTMRI plus AI plus robotics, in that order
Promaxo MRI System
The flagship hardware. A single-sided, open, low-fringe-field magnet that performs MRI-guided prostate biopsy in a standard exam room. FDA 510(k) cleared. No diagnostic-grade rating - that line is held by hospital scanners - but plenty of acuity for image-guided intervention.
AI Imaging Suite
Pre-programmed sequences, image reconstruction, and lesion-targeting algorithms designed to wring clinical utility out of a non-traditional field. Several AI features remain investigational, pending further clearances.
Robotic Needle Guidance
Robotics that operate under live MR guidance, aimed at making targeted biopsy - and, eventually, focal therapy - faster, more repeatable, and less dependent on operator hand-eye athletics. Currently investigational.
The stack reads like a deck slide until you remember the constraint: all of this has to fit in a room, run on standard building power, and be operated by a clinical team that is not staffed with MRI physicists. The product is the integration. The hardware alone is not the moat.
§ 05 - HOW WE GOT HEREA medtech timeline, mostly quiet
§ 06 - PROOF, OR THE PURSUIT OF ITPatents, partners, and a pile of dollars
The case for Promaxo, beyond the clearance, rests on three external signals. First, a portfolio of more than sixty patents, suggesting that the single-sided approach has accumulated a meaningful technical moat. Second, partnership and capital from Zydus Lifesciences - a name with weight in the global pharmaceutical industry - which validates the platform as more than a regional curiosity. Third, the willingness of urology practices to actually buy and install the thing. Hardware sales in medtech are a stiff test.
§ 07 - THE MISSIONImprove lives, with a magnet
The official mission statement is the kind of thing every medtech company writes: improve lives through state-of-the-art medical imaging, robotics, and AI. The unofficial mission is more interesting. It is a quiet argument that the right unit of innovation in modern medicine is the workflow, not the device. A scanner that produces the most beautiful images in the world is useless if the patient cannot get to it, the radiologist cannot read it in time, and the urologist cannot act on the result the same day.
Promaxo's wager is that compressing the entire diagnostic-to-treatment loop into one room, one visit, one clinician's calendar, changes outcomes. Maybe not in the dramatic way a new chemotherapy does, but in the boring, durable way that better logistics always do: more people get cared for, sooner, with less inconvenience, at lower system cost.
§ 08 - TOMORROWWhy the next room matters
If single-sided MRI works for the prostate, the question becomes: what else fits in a single-sided field? Breast. Knee. Wrist. Pediatric imaging. Anywhere a clinic-grade scanner could replace a hospital-grade workflow. Promaxo has not promised any of these, and would be wise not to. But the architecture is, in principle, extensible. Other anatomies are other product lines.
There is also a quieter shift underway in how American medicine is paid for - ambulatory surgery centers, outpatient procedures, and value-based care models all reward exactly the workflow Promaxo enables. The reimbursement codes for MRI-guided prostate procedures already exist. The hardware to take advantage of them did not. Now it does.
§ 09 - BACK TO THE OFFICEThe room, revisited
Return to the clinic. The patient is on the table next to a magnet that hums a little less than the ones he has seen on television. The urologist - the same person who has been managing his care for years - operates the workflow herself. The image comes up. A target is identified. A needle, guided by software, finds the lesion. The whole episode takes the time of a long lunch, not a lost day.
That is the room Promaxo wants to be unremarkable. Not the cutting edge of anything. Not a curiosity in a vendor booth. Just the room down the hall, where prostate care happens, with the magnet on the table and the patient walking out under his own steam. There is no drama in that picture. That is the point.